Cordlife Group (SG:P8A) has released an update.
Cordlife Group Limited has lost its AABB accreditation for cord blood activities due to the continued closure mandated by the Ministry of Health, preventing the identification of non-conforming products and the implementation of corrective measures. The company is actively working on rectification measures to address non-compliance and plans to seek re-accreditation once allowed to resume operations by the MOH. The AABB has expressed willingness to work with Cordlife Group in the future, pending resolution of quality issues and reinstatement of operations.
For further insights into SG:P8A stock, check out TipRanks’ Stock Analysis page.
